These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32415419)

  • 21. Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline.
    Bugatti S; De Stefano L; Bobbio-Pallavicini F; Montecucco C
    RMD Open; 2020 Oct; 6(3):. PubMed ID: 33087414
    [No Abstract]   [Full Text] [Related]  

  • 22. The coronavirus outbreak could make it quicker and easier to trial drugs.
    Ledford H
    Nature; 2020 Jun; 582(7811):172. PubMed ID: 32504019
    [No Abstract]   [Full Text] [Related]  

  • 23. Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.
    Peschken CA
    J Rheumatol; 2020 Jun; 47(6):787-790. PubMed ID: 32269064
    [No Abstract]   [Full Text] [Related]  

  • 24. Chiral distinction between hydroxychloroquine enantiomers in binding to angiotensin-converting enzyme 2, the forward receptor of SARS-CoV-2.
    Aiello F; Balzano F; Uccello Barretta G; D'Acquarica I; Mazzoccanti G; Agranat I
    J Pharm Biomed Anal; 2024 Jan; 237():115770. PubMed ID: 37879140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular effects and retinopathy induced by hydroxychloroquine during SARS-CoV-2 therapy: Role of CYP450 isoforms and epigenetic modulations.
    Paniri A; Hosseini MM; Rasoulinejad A; Akhavan-Niaki H
    Eur J Pharmacol; 2020 Nov; 886():173454. PubMed ID: 32763298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases.
    Dos Reis Neto ET; Kakehasi AM; de Medeiros Pinheiro M; Ferreira GA; Marques CDL; da Mota LMH; Dos Santos Paiva E; Pileggi GCS; Sato EI; Reis APMG; Xavier RM; Provenza JR
    Adv Rheumatol; 2020 Jun; 60(1):32. PubMed ID: 32517786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comment on "Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?".
    Cure E; Cumhur Cure M; Kucuk A
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):345-346. PubMed ID: 32588188
    [No Abstract]   [Full Text] [Related]  

  • 28. Hydroxychloroquine induces oxidative DNA damage and mutation in mammalian cells.
    Besaratinia A; Caliri AW; Tommasi S
    DNA Repair (Amst); 2021 Oct; 106():103180. PubMed ID: 34298488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatal arrhythmias: Another reason why doctors remain cautious about chloroquine/hydroxychloroquine for treating COVID-19.
    Uzelac I; Iravanian S; Ashikaga H; Bhatia NK; Herndon C; Kaboudian A; Gumbart JC; Cherry EM; Fenton FH
    Heart Rhythm; 2020 Sep; 17(9):1445-1451. PubMed ID: 32479900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug in Drug: A Host-Guest Formulation of Azocalixarene with Hydroxychloroquine for Synergistic Anti-Inflammation.
    Li S; Ma R; Hu XY; Li HB; Geng WC; Kong X; Zhang C; Guo DS
    Adv Mater; 2022 Aug; 34(32):e2203765. PubMed ID: 35680644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial performance index: Is it time to revisit this old parameter in COVID-19 patients?
    Timóteo AT
    Rev Port Cardiol; 2022 Jun; 41(6):463-464. PubMed ID: 35194314
    [No Abstract]   [Full Text] [Related]  

  • 32. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac Toxicity of Chloroquine or Hydroxychloroquine in Patients With COVID-19: A Systematic Review and Meta-regression Analysis.
    Tleyjeh IM; Kashour Z; AlDosary O; Riaz M; Tlayjeh H; Garbati MA; Tleyjeh R; Al-Mallah MH; Sohail MR; Gerberi D; Bin Abdulhak AA; Giudicessi JR; Ackerman MJ; Kashour T
    Mayo Clin Proc Innov Qual Outcomes; 2021 Feb; 5(1):137-150. PubMed ID: 33163895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.
    Bosaeed M; Mahmoud E; Hussein M; Alharbi A; Alsaedy A; Alothman A; Aljeraisy M; Alqahtani H; Nashabat M; Almutairi B; Almaghaslah M; Aldibasi O; AlJohani S; Bouchama A; Arabi Y; Alaskar A
    Trials; 2020 Oct; 21(1):904. PubMed ID: 33129363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxychloroquine is effective, and consistently so when provided early, for COVID-19: a systematic review.
    Prodromos C; Rumschlag T
    New Microbes New Infect; 2020 Nov; 38():100776. PubMed ID: 33042552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential link between inherited G6PD deficiency, oxidative stress, and vitamin D deficiency and the racial inequities in mortality associated with COVID-19.
    Jain SK; Parsanathan R; Levine SN; Bocchini JA; Holick MF; Vanchiere JA
    Free Radic Biol Med; 2020 Dec; 161():84-91. PubMed ID: 33038530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implications of Oxidative Stress and Potential Role of Mitochondrial Dysfunction in COVID-19: Therapeutic Effects of Vitamin D.
    de Las Heras N; Martín Giménez VM; Ferder L; Manucha W; Lahera V
    Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32967329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global COVID-19 Efforts as the Platform to Achieving the Sustainable Development Goals.
    Mejia R; Hotez P; Bottazzi ME
    Curr Trop Med Rep; 2020; 7(4):99-103. PubMed ID: 32844081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxychloroquine use in COVID-19: is the risk of cardiovascular toxicity justified?
    Stevenson A; Kirresh A; Conway S; White L; Ahmad M; Little C
    Open Heart; 2020 Aug; 7(2):. PubMed ID: 32817375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are the Clinical Presentations (Phenotypes) of Gitelman's and Bartter's Syndromes Gene Mutations Driven by Their Effects on Intracellular pH, Their "pH" Enotype?
    Calò LA; Davis PA
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.